MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive: For instance, increased Musashi2 expression is thought to be prognostic in CML since it is associated with poor outcomes, but it also plays a mechanistic function in increasing leukemia stem cell survival and suppressing Numb, which shows how the disease develops at the molecular level.